In a profession that supports the health and wellbeing of the public, pharmacists must have regular protected learning time to enable them to carry out their crucial roles.
Warm words are not enough for community pharmacySubscription
Community pharmacies have worked tirelessly during the COVID-19 pandemic; it is time they were given additional funding to help them prepare for the next wave.
The COVID-19 pandemic has changed the pharmacy profession in many ways, but perhaps the longest-lasting could be the planned changes to the preregistration year.
NOW EXTENDED: A brave new world? Share your ideas on post-pandemic pharmacy in our writing competitionSubscription
Flex your creative skills and enter our annual writing competition this year.
With doubts around the accuracy of antibody tests and slow progress on point-of-care testing, it is likely we will be waiting some time before we can confidently screen for COVID-19.
Action is needed as a 15-percentage-point gap between white and black pharmacy students awarded upper class MPharm degrees is revealed.
False penicillin allergies are placing patients at risk of resistant infections and are a threat to antimicrobial stewardship; we must safely de-label patients to avoid these costs to public health.
The high proportion of people from black, Asian and minority ethnic groups dying from COVID-19 has brought health inequalities between ethnic groups to the fore, but this should have been looked into long before the pandemic began.
The pharmacy sector must not underestimate the extent to which the COVID-19 pandemic will transform the NHS.
While news of imminent serology testing is incredibly encouraging, we must be pragmatic about how quickly it can be made available to the general public.
Dozens of drug candidates are being trialled for both prophylaxis and treatment of COVID-19, but it is too early to recommend any of them for routine clinical use.